14523280

Source:http://linkedlifedata.com/resource/pubmed/id/14523280

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0026565, umls-concept:C0887947, umls-concept:C1836233
pubmed:issue	15
pubmed:dateCreated	2003-10-2
pubmed:abstractText	To examine survival and progression to AIDS among HIV-infected patients after starting highly active antiretroviral therapy (HAART).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/14523280-14523285
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8710219
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0269-9370
pubmed:author	pubmed-author:ATHENA Cohort Study Group, pubmed-author:BrinkmanKeesK, pubmed-author:GhaniAzra CAC, pubmed-author:GyssensInge CIC, pubmed-author:JambroesMariëlleM, pubmed-author:LangeJoep M AJM, pubmed-author:ReissPeterP, pubmed-author:de WolfFrankF, pubmed-author:van SighemArd IAI, pubmed-author:van de WielMark AMA
pubmed:issnType	Print
pubmed:day	17
pubmed:volume	17
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2227-36
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:14523280-Acquired Immunodeficiency Syndrome, pubmed-meshheading:14523280-Adult, pubmed-meshheading:14523280-Age Factors, pubmed-meshheading:14523280-Antiretroviral Therapy, Highly Active, pubmed-meshheading:14523280-CD4 Lymphocyte Count, pubmed-meshheading:14523280-Disease Progression, pubmed-meshheading:14523280-Female, pubmed-meshheading:14523280-HIV Infections, pubmed-meshheading:14523280-Humans, pubmed-meshheading:14523280-Incidence, pubmed-meshheading:14523280-Male, pubmed-meshheading:14523280-Middle Aged, pubmed-meshheading:14523280-Models, Biological, pubmed-meshheading:14523280-Prognosis, pubmed-meshheading:14523280-Prospective Studies
pubmed:year	2003
pubmed:articleTitle	Mortality and progression to AIDS after starting highly active antiretroviral therapy.
pubmed:affiliation	HIV Monitoring Foundation, Academic Medical Centre of the University of Amsterdam, Amsterdam, The Netherlands. A.I.vanSighem@amc.uva.nl
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't